Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Long-Term Deferred Tax (2015 - 2025)

Palatin Technologies' (PTN) quarterly Long-Term Deferred Tax came in at $46.1 million in Q2 2025, down 26.56% YoY from $62.7 million in Q2 2024, and down 26.56% on a QoQ basis from $62.7 million in Q2 2024.

Palatin Technologies (PTN) Long-Term Deferred Tax (2015 - 2025) Analysis & Trends

Palatin Technologies (PTN) has 10 years of Long-Term Deferred Tax data on file, last reported at $46.1 million in Q2 2025.

  • Quarterly Long-Term Deferred Tax fell 26.56% year-over-year to $46.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $46.1 million (down 26.56% YoY) and the FY2025 annual result came in at $46.1 million, down 26.56% from the prior year.
  • Long-Term Deferred Tax slipped to $46.1 million in Q2 2025, from $62.7 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $62.7 million in Q2 2024 to a low of $32.2 million in Q2 2021.
  • A 4-year average of $44.1 million and a median of $40.7 million in 2022 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2022 — Long-Term Deferred Tax rose 9.83% — and 2025, when it slipped 26.56%.
  • Tracing PTN's Long-Term Deferred Tax over 4 years: stood at $32.2 million in 2021, then increased by 9.83% to $35.3 million in 2022, then jumped by 77.49% to $62.7 million in 2024, then slipped by 26.56% to $46.1 million in 2025.
  • The last three Long-Term Deferred Tax figures came in at $46.1 million (Q2 2025), $62.7 million (Q2 2024), and $35.3 million (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Palatin Technologies 40.37 Mn 40.37 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 46.05 Mn
Jun 30, 2024 62.71 Mn
Jun 30, 2022 35.33 Mn
Jun 30, 2021 32.17 Mn
Jun 30, 2020 32.42 Mn
Jun 30, 2019 26.59 Mn
Jun 30, 2018 29.50 Mn
Sep 30, 2017 274,745.00
Jun 30, 2016 125.54 Mn
Jun 30, 2015 102.90 Mn